Analysis of cost and effectiveness of pre-transfusion screening of donor blood and anti-malarial prophylaxis for recipients

East African Medical Journal

Volumn 82, Issue 11, 2005, Pages 565-571

  Rajab, J A ^a   Waithaka, P M ^a   Orinda, D A O ^b   Scott, C S ^c  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b Abbott Diagnostics Division   (Kenya)

^c ABBOTT GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; ECONOMICS; HUMAN; KENYA; MALARIA; MASS SCREENING;

ANTIMALARIALS; BLOOD DONORS; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; HUMANS; KENYA; MALARIA; MASS SCREENING;

EID: 32344442628     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Edward, L. S. and Roger, Y. D. Reducing the risk of blood transfusion. Amer. Soc. Hemat. 2001; 433-442.
2. Slinger, R., Giulivi, A., Margaret, B., Falid, H. et al. Transfusion-transmitted malaria in Canada. CMAJ 2001; 164:377-379.
3. Mungai, M., Tegtmeier, G., Chamberl and M., Parise M. Transfusion transmitted malaria in the US from 1963 through to 1999. N. Engl. J. Med. 2001; 344:1973-1978.
4. Reesink, H. European strategies against the parasite transfusion risk. Transfus. Clin. Biol. 2005; 12:1-4.
5. Kenya MoH, (Ministry of Health) Policy guidelines on blood transfusion in Kenya. The National Blood Transfusion Services of Kenya. November, 2001.
6. http:www.who.int /reproductive-health/impac/Clinical principles/clinical use of blood, blood products and replacement fluid.
7. Beadle, C., Long, G. W., Weiss, W. R. et al. Diagnosis of Malaria by detection of plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen capture assay. Lancet 1994; 343:564-568.
8. Piper, R., Lebras, J., Wentworth, L. et al. Immunocapture diagnostic assays for malaria using plasmodium lactate dehydrogenase (pLHD). Amer. J. Trop. Med. Hyg. 1999; 60:109-118.
9. Scott, C. S., van Zyl, D., Ho E., Meyersfeld, D. et al. Automated detection of WBC intracellular malaria-associated Pigment (hemozoin) with Abbott Cell-Dyn 3200 and Cell-Dyn 3700 analyzers: Overview and results from the South African Institute for Medical Research SAIMR) II evaluation. Lab. Hematol. 2002; 8:91-101.
10. Mendelow, B. V., Lyons, C., Nhlangothi, P., Tana, M. et al. Automated malaria detection by depolarization of laser light. Brit. J. Haematol. 1999; 104:499-503.
11. Sachse, C., Jahns-Streubel G. and Henkel E. Evaluation of leukocyte differential count information from the Cell-Dyn 3200 hematology analyzer. Lab Hematol. 1999; 5:137-148.
12. WHO 2002- Division of Centers of Tropical Diseases WHO 2002; 13:
13. Awad, A. S., Abdul M., Ibrahim, N. et al. Malaria screening of blood donors in Saudi Arabia. Annals Saud Med. 2002; 22:329-332.
14. Gunter, M. J. The role of the ECHO Model in outcomes research and clinical practice improvement. Amer. J. Managed Care. 1999; 5:5217-5224.
15. Herman, P. M., Craig, B. M. and Caspi, O. Is complementary and alternative medicine (CAM) cost effective? A systematic review. BMC complementary and alternative medicine. 2005; 5: 11 doi: 10.1186/1472-6882. http:www.biomedcentral.com.
16. Arese, P. and Schwarzer, E. Malarial pigment (haemozoin): a very active 'inert' substance. Ann. Trop. Med. Parasitol. 1997; 91:510-516.
17. Panday, A. V. and Tekwani, B. L. Formation of haemozoin/beta-haematin under physiological conditions is not spontaneous. FEBS Lett. 1996; 393:189-193.
18. Arese, P. and Schwarzer, E. Malarial pigment (haemozoin): a very active 'inert' substance. Ann Trop Med Parasitol. 1997; 91:510-516.
19. Lawrence, C. and Olson, J. A. Birefringent hemozoin identifies malaria. Amer. J. Clin. Pathol. 1986; 86:360-363.
20. Hempelmann, E., and Marques, H. M. Analysis of malaria pigment from Plasmodium falciparum. J. Pharm Toxicol Meth. 1994; 32:25-30.
21. Day, N. P., Pham, T. D., Phan, T. L., Dinh T. L. et al. Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. Blood. 1996; 88:4694-4700.
22. Ogutu, B. R. malaria Diagnosis (Editorial). East Afr. Med. J. 2005; 82:109-110.
23. WHO/29 (22 April 2004) Press release. More than 600 million people urgently need effective malaria treatment to prevent unacceptable high death rates. http://www.who.int/mediacentre.
24. Gamman, M., Atebe, R., Diara, P. and Karim, R. Malaria: The challenges of increasing resistance of chemotherapy. Pharma Med. J. 2005; 1:20-21.